Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives
International Journal of Molecular Sciences · 29.09.2024 · 25 (19) · 10488
DOI: 10.3390/ijms251910488 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.09.2024. Verfasst von Bence Bojtor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary. Hauptthemen laut MEDLINE: Bisphosphonate-Associated Osteonecrosis of the Jaw, Genetic Predisposition to Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Research Network, Ministry of Innovation and Technology.
Abstract (Originalsprache)
Medication-related osteonecrosis of the jaw (MRONJ) is a rare side effect of antiresorptive drugs that significantly hinders the quality of life of affected patients. The disease develops in the presence of a combination of factors. Important pathogenetic factors include inflammation, inhibition of bone remodeling, or genetic predisposition. Since the first description of this rare side effect in 2003, a growing body of data has suggested a possible role for genetic factors in the disease. Several genes have been suggested to play an important role in the pathogenesis of MRONJ such as SIRT1, VEGFA, and CYP2C8. With the development of molecular biology, newer methods such as miRNA and gene expression studies have been introduced in MRONJ, in addition to methods that can examine the base sequence of the DNA. Describing the complex genetic background of MRONJ can help further understand its pathophysiology as well as identify new therapeutic targets to better manage this adverse drug reaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary.
- Hungarian Research Network SE-ENDOMOLPAT Research Group, 1085 Budapest, Hungary.
- Department of Oro-Maxillofacial Surgery and Stomatology, Semmelweis University, 1085 Budapest, Hungary.
ORCID-Profile: Bence Bojtor
Förderung
- Hungarian Research Network
- Ministry of Innovation and Technology
Zitieren
APA
Bojtor, B., Balla, B., Vaszilko, M., Szentpeteri, S., Putz, Z., Kosa, J. P., & Lakatos, P. (2024). Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives. International Journal of Molecular Sciences, 25(19), 10488. https://doi.org/10.3390/ijms251910488
Vancouver
Bojtor B, Balla B, Vaszilko M, Szentpeteri S, Putz Z, Kosa JP, et al. Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives. International Journal of Molecular Sciences. 2024;25(19):10488. doi:10.3390/ijms251910488
BibTeX
@article{Bojtor2024,
author = {Bojtor, Bence and Balla, Bernadett and Vaszilko, Mihaly and Szentpeteri, Szofia and Putz, Zsuzsanna and Kosa, Janos P and Lakatos, Peter},
title = {Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {19},
pages = {10488},
doi = {10.3390/ijms251910488}
}
EUVIMED